Hideyuki Harada

4.5k total citations · 1 hit paper
144 papers, 3.2k citations indexed

About

Hideyuki Harada is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hideyuki Harada has authored 144 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Pulmonary and Respiratory Medicine, 70 papers in Oncology and 36 papers in Surgery. Recurrent topics in Hideyuki Harada's work include Lung Cancer Treatments and Mutations (53 papers), Lung Cancer Diagnosis and Treatment (47 papers) and Lung Cancer Research Studies (42 papers). Hideyuki Harada is often cited by papers focused on Lung Cancer Treatments and Mutations (53 papers), Lung Cancer Diagnosis and Treatment (47 papers) and Lung Cancer Research Studies (42 papers). Hideyuki Harada collaborates with scholars based in Japan, United States and United Kingdom. Hideyuki Harada's co-authors include Tetsuo Nishimura, Hirofumi Asakura, Takashi Katsumata, Masashi Nakatsuka, Toshiaki Takahashi, Shuzo Tagashira, Hirohisa Katagiri, Yoko Nakasu, Masahiro Endo and Shinji Ogawa and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hideyuki Harada

133 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial

2017 308 citations Toshiaki Takahashi, Hideyuki Harada et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideyuki Harada Japan	28	1.6k	1.5k	876	616	458	144	3.2k
P N Plowman United Kingdom	28	773 0.5×	726 0.5×	955 1.1×	482 0.8×	493 1.1×	94	2.8k
Uğur Selek Türkiye	26	1.0k 0.6×	958 0.6×	758 0.9×	178 0.3×	389 0.8×	144	2.5k
Annie Rey France	40	2.4k 1.5×	1.0k 0.7×	1.5k 1.7×	590 1.0×	459 1.0×	78	4.7k
Kathryn E. Dusenbery United States	34	1.0k 0.6×	1.1k 0.7×	529 0.6×	751 1.2×	481 1.1×	126	4.6k
Rodney E. Wegner United States	24	907 0.6×	782 0.5×	545 0.6×	269 0.4×	457 1.0×	174	2.2k
Kaitlin M. Woo United States	29	1.2k 0.8×	1.3k 0.9×	302 0.3×	404 0.7×	225 0.5×	66	2.7k
Juergen Dunst Germany	33	1.5k 1.0×	1.2k 0.8×	1.5k 1.7×	410 0.7×	301 0.7×	118	4.0k
Weining Zhen United States	22	932 0.6×	562 0.4×	892 1.0×	320 0.5×	308 0.7×	67	2.7k
Max Seidensticker Germany	27	788 0.5×	806 0.5×	985 1.1×	270 0.4×	462 1.0×	197	3.1k
Andrew J. Bishop United States	26	1.1k 0.7×	623 0.4×	850 1.0×	198 0.3×	297 0.6×	124	2.2k

Countries citing papers authored by Hideyuki Harada

Since Specialization

Citations

This map shows the geographic impact of Hideyuki Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Harada more than expected).

Fields of papers citing papers by Hideyuki Harada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Harada. The network helps show where Hideyuki Harada may publish in the future.

Co-authorship network of co-authors of Hideyuki Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Harada. A scholar is included among the top collaborators of Hideyuki Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Harada. Hideyuki Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsuboi, Masahiro, Haruyasu Murakami, Hideyuki Harada, et al.. (2024). Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study. Thoracic Cancer. 15(20). 1541–1552. 1 indexed citations

Takeuchi, Kazuhito, et al.. (2023). Endoscopic debulking canalization for optic pathway glioma with obstructive hydrocephalus. Child s Nervous System. 39(12). 3421–3425. 1 indexed citations

Omori, Shota, Takanori Kawabata, Naoya Nishioka, et al.. (2022). Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy. Advances in Radiation Oncology. 8(2). 101129–101129. 4 indexed citations

Miyawaki, Taichi, Hirotsugu Kenmotsu, Naoya Nishioka, et al.. (2022). Clinical impact of tumour burden on the efficacy of PD‐1/PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer. Cancer Medicine. 12(2). 1451–1460. 4 indexed citations

Takeuchi, Kazuhito, Fumiharu Ohka, Yuichi Nagata, et al.. (2022). Endoscopic Trans-Mini-Cylinder Biopsy for Intraparenchymal Brain Lesions. World Neurosurgery. 167. e1147–e1153. 3 indexed citations

Miyawaki, Taichi, Hirotsugu Kenmotsu, Hideyuki Harada, et al.. (2021). Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L). BMC Cancer. 21(1). 1121–1121. 5 indexed citations

Kubota, Hikaru, Naoki Nakamura, Naoto Shikama, et al.. (2020). Practice patterns for postoperative radiation therapy in patients with metastases to the long bones: a survey of the Japanese Radiation Oncology Study Group. Journal of Radiation Research. 62(2). 356–363. 2 indexed citations

Miyawaki, Taichi, Kazushige Wakuda, Hirotsugu Kenmotsu, et al.. (2020). Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy. Cancer Science. 112(1). 359–368. 8 indexed citations

Horinouchi, Hidehito, Shinji Atagi, Satoshi Oizumi, et al.. (2020). Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study. Cancer Medicine. 9(18). 6597–6608. 31 indexed citations

10.

Mitsuya, Koichi, Yoko Nakasu, Nakamasa Hayashi, et al.. (2020). Retrospective analysis of salvage surgery for local progression of brain metastasis previously treated with stereotactic irradiation: diagnostic contribution, functional outcome, and prognostic factors. BMC Cancer. 20(1). 331–331. 10 indexed citations

11.

Kimura, Fumiaki, et al.. (2019). Successful endovascular repair of a ruptured isolated iliac artery aneurysm: A case report. SHILAP Revista de lepidopterología. 7(10). 1880–1884. 4 indexed citations

12.

Akamatsu, Hiroaki, Hideyuki Harada, Shoji Tokunaga, et al.. (2018). A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non–small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L). Clinical Lung Cancer. 20(1). e25–e27. 18 indexed citations

13.

Mitsuya, Koichi, Junichiro Watanabe, Yoko Nakasu, et al.. (2016). Expansive hematoma in delayed cerebral radiation necrosis in patients treated with T-DM1: a report of two cases. BMC Cancer. 16(1). 391–391. 15 indexed citations

14.

Hashii, H., Masashi Mizumoto, Ayae Kanemoto, et al.. (2011). Radiotherapy for Patients with Symptomatic Intramedullary Spinal Cord Metastasis. Journal of Radiation Research. 52(5). 641–645. 38 indexed citations

15.

Kanemoto, Hideyuki, Katsuhiko Uesaka, Hiroyoshi Furukawa, et al.. (2007). . Kanzo. 48(2). 79–84. 2 indexed citations

16.

Takahashi, Toshiaki, Fumiyoshi Ohyanagi, Atsushi Horiike, et al.. (2007). P2-217: Phase II study of TS-1(S) plus cisplatin(P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S658–S658. 2 indexed citations

17.

Murayama, Shigeyuki, Hiroshi Fuji, Haruo Yamashita, et al.. (2005). [Initial clinical experience of proton therapy at Shizuoka Cancer Center].. PubMed. 65(4). 424–31. 3 indexed citations

18.

Harada, Hideyuki, et al.. (2002). Composite graft replacement after aortic valvuloplasty in Takayasu arteritis. The Annals of Thoracic Surgery. 73(2). 644–647. 7 indexed citations

19.

Harada, Hideyuki, Yoshikazu Kuboi, Rika Miki, et al.. (1998). Cloning of Rabbit TR4 and Its Bone Cell-Specific Activity to Suppress Estrogen Receptor-Mediated Transactivation¹. Endocrinology. 139(1). 204–212. 13 indexed citations

20.

Ebihara, Kanae, Yoshikazu Masuhiro, Takuya Kitamoto, et al.. (1996). Intron Retention Generates a Novel Isoform of the Murine Vitamin D Receptor That Acts in a Dominant Negative Way on the Vitamin D Signaling Pathway. Molecular and Cellular Biology. 16(7). 3393–3400. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact